Acadia Healthcare Company (ACHC) Could Be 5% Undervalued As Earnings Stir Valuation Questions
Acadia Healthcare’s latest earnings trigger fresh look at the stock
Acadia Healthcare Company (ACHC) just released third quarter 2026 results, with higher sales and lower profit than a year ago. That mix gives investors fresh numbers to reassess the behavioral health operator.
The earnings release has arrived alongside a sharp change in the market’s expectations. Acadia Healthcare Company’s share price is up 8.88% over one day and 11.71% over 30 days, contributing to a 125.68% year to date share price return. However, the 3 year total shareholder return is down 56.24%, which indicates that the recent momentum is a sharp break from a much weaker longer history.
Scan how Acadia Healthcare’s surge compares with other hand-picked healthcare operators showing resilient profitability and balance sheets using the list of solid balance sheet and fundamentals (24 results)
Acadia Healthcare’s share price has sprinted ahead while earnings have been slower to move, which leaves a simple tension. Has the recent rally already captured most of the value, or is there still clear upside on offer once you run the numbers?
Most Popular Narrative: 4.5% Undervalued
Acadia Healthcare’s most followed valuation narrative pegs fair value at $33.79 per share, slightly above the latest close at $32.25. This places the current rally in the context of assumptions about future cash generation and risk.
New facility cohorts opened between 2023 and 2026 that are performing ahead of internal expectations, including some locations already above 90% occupancy and positive facility-level EBITDA, together with a company target for these cohorts to add about US$200 million of incremental adjusted EBITDA relative to 2025, provide a visible path for future EBITDA and earnings contribution as they mature.
See why 2 investors see Acadia Healthcare Company as 5% undervalued.
Result: Fair Value of $33.79 (UNDERVALUED)
Still, this upbeat Acadia Healthcare story can fracture if legal investigations lead to larger settlements or if payer denials and bad debts bite harder than expected.
Find out about the key risks to this Acadia Healthcare Company narrative.
Next Steps
Mixed signals around Acadia Healthcare’s valuation and risks make this a decision you cannot outsource to headlines or a single narrative. Take a moment to weigh both the concerns and potential upsides for yourself by reviewing the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Acadia Healthcare?
Do not stop with Acadia Healthcare if you want a fuller watchlist. Fresh opportunities appear quickly, and the investors who review them early keep more options.
- Target dependable income potential by scanning companies that qualify as 5 dividend fortresses for a mix of yield and balance sheet support.
- Track compelling value setups by reviewing our 19 high quality undiscovered gems, where fundamentals help highlight businesses the crowd may have overlooked.
- Prioritise capital protection first and hunt through the 31 resilient stocks with low risk scores to see which stocks carry lower overall risk scores.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com